Art-eating fungus attacks Rome's ancient underground frescoes

A devastating infestation of microbugs is damaging the treasured underground frescoes that decorate the labyrinths of ancient catacombs beneath Rome.
A vast network of tunnels, dug into the soft, porous tufa rock that underlies much of the city, was created in the early Christian era for the burial of the dead. They were also used as clandestine meeting places at a time when Christians were persecuted by Rome's emperors.
But the colourful frescoes that adorn the ceilings and walls of the catacombs are being eaten away by microorganisms, a phenomenon that experts say is being accelerated by climate change.
Rising temperatures have increased humidity levels inside the underground burial sites, encouraging the growth of bacteria, moss and fungus.
The alarm about the rampant art-eating fungus has been raised by a Vatican department, the Pontifical Commission for Sacred Archaeology.
'The survival of frescoes which were created 2,000 years ago is at risk,' said Monsignor Pasquale Iacobone, the head of the department.
'There is an increase in the proliferation of vegetation, and the damage is unprecedented. It's the effect of climate change and the increase in outside temperatures.'
Ancient Romans, who cremated their dead, banned Christians from burying corpses within the walls of the capital.
So the Christians instead dug underground passageways for the interment of their dead, eventually excavating around 300 km of tunnels beneath Rome.
They wrapped the dead in shrouds and laid them to rest in rectangular niches that were carved out of the tunnel walls.
Among the treasures under threat are striking frescoes in the San Callisto Catacomb, which mark some of the earliest surviving examples of Christian art.
San Callisto, the biggest and most famous of Rome's catacombs, was established in the second century AD and contained the remains of about half a million people, as well as seven popes who were martyred in the third century AD.
'Along with the six catacombs that are open to the public, the problem is affecting all 400 of the decorated chambers that exist in Rome's 60 catacombs. We are seeing an unexpected increase in biological infestations,' Barbara Mazzei, an archaeologist and an expert on the catacombs, told Corriere della Sera newspaper.
While the problem underground is high humidity, the issue above ground is a lack of moisture – high temperatures and drought conditions mean that trees are sinking their roots deeper, breaking through the ceilings of the catacombs and penetrating the frescoes.
The confined, subterranean nature of catacombs and the lack of ventilation mean that it is hard for experts to use chemicals such as biocides to combat the growth of bacteria and mould.
Instead, they are experimenting with natural products that are not harmful to humans, including essential oils made from lavender, thyme and cinnamon.
The threats faced by the catacombs were revealed at a seminar in Rome organised by the International Institute for Conservation of Historic and Artistic Works.
Many of the catacombs lie beneath the Appian Way, the 'regina viarum' or 'queen of roads' that once ran from Rome to the distant port of Brindisi on the Adriatic coast.
In 2010, the earliest known icons of four of Christ's apostles were discovered on the ceiling of an elaborately decorated chamber in a catacomb beneath the streets of Rome.
Scientists used advanced laser technology to remove a hardened crust of dirt and calcium deposits to bring to light the brightly coloured fourth-century paintings of Saints John, Paul, Andrew and Peter.
The images adorn the ceiling of a vault, carved out of volcanic rock, which provided the last resting place of a rich Roman noblewoman who converted to Christianity.
Archaeologists also found an early image of Christ, a painting of a naked Daniel with lions at his feet and a sketch of Jesus raising Lazarus from the dead.
The catacombs of Santa Tecla, a labyrinth of tunnels, galleries and burial chambers, lie hidden beneath a five-storey office in Ostiense, a residential area of Rome.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mail​

4 hours ago

• Daily Mail​

Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons

A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.

The Independent

6 hours ago

• The Independent

Weight loss jab could be used to treat migraines

Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.

Reuters

12 hours ago

• Reuters

Dassault Aviation gets French government support for its VORTEX spaceplane demonstrator

PARIS, June 20 (Reuters) - Dassault Aviation ( opens new tab and the French government signed on Friday an agreement whereby France's armed forces ministry would support the development of Dassault Aviation's VORTEX spaceplane demonstrator. The agreement was signed at the Paris Airshow between French armed forces minister Sebastien Lecornu and Dassault Aviation CEO and Chairman Eric Trappier. The government support for the Dassault Aviation VORTEX project comes as President Emmanuel Macron on Friday threw France's backing behind plans for a European satellite manufacturing champion. At the Paris Airshow, Macron also called for accelerated deployment of Starlink-type satellites as he declared space the new theatre for world power competition. "At the crossroads of aviation and space technologies, the VORTEX will undoubtedly pave the way for a new generation of space aeronautics, consolidating France's strategic position as a leading space power," said Eric Trappier in a statement.